Our website uses cookies to distinguish you from other users of our website to provide you with the most relevant experience by remembering your preferences and repeat visits. By clicking on ‘Accept’ you consent to our cookie policy. However, you may visit ‘Cookie Settings’ to provide a controlled consent.

Accept

News

Archive

PlanetiQ awarded $6.5 Million NOAA contract to supply Radio Occultation data for the commercial weather pilot data program Ventyx Biosciences announces initiation of dosing in a Phase 2a trial of VTX3232 in patients with early Parkinson’s disease Vascular Therapies completes enrollment in the ACCESS 2 study, a Phase III multinational randomized clinical trial of the Sirolimus Eluting Collagen Implant (Sirogen™) for the surgical creation of arteriovenous fistula for hemodialysis vascular access Ventyx Biosciences announces results from the Phase 2 trial of VTX958 in participants with moderately to severely active Crohn’s disease Emporos and InterLink AI Partner, develop only POS-Integrated lighted will-call solution Phase Four partners with Redwire to expand space propulsion offerings and deliver Hall Effect Thrusters
Back To News
TherOx Receives FDA Approval for the First Heart Attack Treatment Since PCI to Reduce Infarct Size
April 4, 2019

TherOx Receives FDA Approval for the First Heart Attack Treatment Since PCI to Reduce Infarct Size

View Full Press Release >>

Cookie Policy Website powered by 100% renewable energy Privacy Policy